RdRP-IN-9 (Compound 6b) is a reversible covalent allosteric inhibitor of RdRp . RdRP-IN-9 demonstrates high anti-coronavirus activity, with an EC 50 value of 0.68 μM against HCoV-OC43 RdRP-IN-9 exerts a more prolonged antiviral effect by reversibly acylating Cys12 in the NiRAN domain of non-structural protein 12 ( nsp 12 ) and exhibits synergistic anti-coronavirus activity with Molnupiravir ( HY-135853 ) .
Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > SARS-CoV
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.